All News

A study published in the journal Cancer presents the financial impact of cancer on a survivor and his family.

A new health insurance start-up aiming to aid companies with their employer-sponsored insurance raised $81 million in a new round of financing. The new funding will allow the company to expand its services beyond California in 2016.

Two head-to-head trials comparing the safety of Incruse Ellipta to 2 available bronchodilator treatments used by patients with chronic obstructive pulmonary disease has yielded positive results for GlaxoSmithKline's therapy.

This week in managed care, documents show Horizon Blue Cross Blue Shield of NJ rolled out OMNIA prior to receiving regulatory approval, 2 Harvard professors argue the merit of the annual physical, and experts weigh in on the successes and flaws of Medicare Part D.

CMS has unveiled the latest improvements to HealthCare.gov. However, the agency was not able to complete all additional features in time for open enrollment and will roll the remaining ones out after November 1.

Years after the country was sent into a tizzy over the fear of "death panels," there has been an enormous growth in palliative care in the United States, although it and hospice care are still very misunderstood by patients, said speakers at America's Health Insurance Plans' National Conference on Medicaid.

The drug is awaiting an FDA verdict next week.

As the date for the comment period on the proposed guidance by HHS on 340B drug pricing draws near, read about the program and its impact on healthcare overall.

GAO made recommendations for safeguards to prevent enrollees from having Medicaid and exchange coverage at the same time.

Published in JAMA Oncology, the study found a significant difference in quality and access to care for black patients diagnosed with localized prostate cancer.

The prospective cohort study adds to the findings that connect lack of sleep to metabolic syndrome and the development of disease.

What we're reading, October 23, 2015: a new definition of dual eligibles, FDA warning on liver toxicity of Abbvie's hepatitis C drug, and Amgen's Repatha can cost patients more than just money.

Tiered and narrow insurance network products are increasing in US health insurance markets, particularly in the health insurance exchange market, according to an analysis by Avalere Health.

Patients with cancer in the urology clinic at a VA hospital in Arizona may have suffered adverse outcomes due to clinical disconnect and staff shortage.

Presenting results of a meta-analysis comparing low-carbohydrate and low-fat diets is never uneventful when the nation is weeks away from adopting the 2015 Dietary Guidelines for Americans.

Patients with metastatic pancreatic cancer who have progressed on gemcitabine now have the option of Onivyde combined with leucovorin/fluorouracil.

Senator Tim Kaine (D-VA) discussed Medicaid expansion, the Affordable Care Act, and politics at America's Health Insurance Plans' National Conference on Medicaid.

Out-of-pocket expenses for medications in typical silver plans are twice as high as they are in employer-sponsored plans, leading patients to fill and refill medications less frequently, which has important health implications.

A study published in the Journal of the American College of Surgeons found that including patients in the Enhanced Recovery program has a dramatic impact on their recovery post surgery.

Soda consumption dropped in Mexico in the year after its soda tax took effect, but the beverage industry is fighting back. Calls continue both here and abroad for taxes to combat obesity.

What We're Reading, October 22, 2015: can aspirin prevent the recurrence of cancer, Clinton wants careful scrutiny of insurance mergers, and small businesses race against time to comply with the ACA.

The drug fills a void for patients with chronic kidney disease, including those with diabetes, who have high potassium levels.

A presentation at the annual meeting of the American Society for Radiation Oncology underscored the importance of patient-centered care and the benefit of incorporating the patient voice in advanced oncology care.

A letter published in JAMA Internal Medicine questions the FDA's acceptance of surrogate endpoints for what the authors describe as "costly, toxic drugs that do not improve overall survival."

Wound care specialists, who treat burn victims and diabetics with foot ulcers, say the move to end coverage if a dressing is made of more than 50% honey by weight is arbitrary and makes no sense from a medical standpoint. A final LCD is pending.

When the Affordable Care Act was proposed more than 6 years ago, the discussion about end-of-life care was limited by political fighting and inertia. Today, there is a greater openness to engaging in this important discussion.

Patients face many obstacles to effective treatment for pelvic floor disorders.

What we're reading, October 21, 2015: influential Republican's on health committees oppose the Affordable Care Act's reinsurance program for insurers; shareholder's of Aetna say yes to the company's merger with Humana; and the genetic testing company will once again start sharing health information with consumers.

A decade after the introduction of the Medicare Part D program and the program has seen great success-but that may be coming to an end. Panelists debated just that and discussed rising drug costs during a session at America's Health Insurance Plans' National Conference on Medicare.

Throughout Governor Terry Branstad's effort to bring Medicaid managed care to Iowa, critics have questioned whether it will limit access for beneficiaries. Contracts have been signed, and now savings are being questioned.